Constructing the Chinese medicine clinical curative effects research report system_Chinese Journal of Evidence-Based Medicine

Authors：

TIAN Ran ¹ , ZHAO Chen ¹ , CHENG Chungwah ¹ , LAM Waiching ¹ , YANG Zhen ¹ , WU Taixiang ² , YANG Kehu ³ , LI Youping ² , SHANG Hongcai ⁴ , LYU Aiping ¹ ,  BIAN Zhaoxiang ¹

1. School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, 999077, P.R.China;
2. Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
3. Evidence-Based Medicine Center, Lanzhou University, Lanzhou, 730000, P.R.China;
4. Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, P.R.China;

Corresponding author：

BIAN Zhaoxiang, Email: bianzxiang@gmail.com

Keywords：

Report specification; Chinese medicine; Clinical trial; Quality of clinical trial

DOI：

10.7507/1672-2531.201801070

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Clinical research reports are the main form of clinical evidence. Based on the requirements of clinical research reports and the characteristics of clinical research on traditional Chinese medicine, it is an important basic systematic project to construct a standardized system of clinical curative effects study report on Chinese medicine. This article elaborates existing problems, focus of attention and construction process in order to help promote the improvement of clinical curative effects research report on Chinese medicine, provide more high-quality evidences for clinical decision-making and promote the development of Chinese medicine.

Citation： TIAN Ran, ZHAO Chen, CHENG Chungwah, LAM Waiching, YANG Zhen, WU Taixiang, YANG Kehu, LI Youping, SHANG Hongcai, LYU Aiping, BIAN Zhaoxiang. Constructing the Chinese medicine clinical curative effects research report system. Chinese Journal of Evidence-Based Medicine, 2018, 18(7): 651-653. doi: 10.7507/1672-2531.201801070 Copy

1.	Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration. Ann Intern Med, 2017, 167(2): 112-121.
2.	Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Traditional Chinese Version). Ann Intern Med, 2017, 167(2): W7-W20.
3.	Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Simplified Chinese Version). Ann Intern Med, 2017, 167(2): W21-W34.
4.	Macpherson H, Altman DG, Hammerschlag R. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med, 2010, 3(3): 35-46.
5.	尚志钧. 神农本草经校注. 北京: 学苑出版社, 2008.
6.	Lewith GT, Aldridge D. Clinical research methodology for complementary therapies. London: Hodder and Stoughton, 1993.
7.	单平, 毛如宝, 徐济民, 等. 黄杨宁治疗冠心病-用双盲法观察 110 例临床疗效分析. 中医杂志, 1983, (5): 37-40.
8.	Mcsp CS. Clinical Research Methodology for Complementary Therapies. Physiotherapy, 1993, 79(6):444.
9.	Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg, 2011, 9(8): 672-677.
10.	Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg, 2010, 8(5): 336-341.
11.	Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev, 2015, 4(1): 1.
12.	Stewart LA, Clarke M, Rovers M, et al. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD Statement. JAMA, 2015, 313(16): 1657-1665.
13.	Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med, 2015, 162(11): 777-784.
14.	Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med, 2013, 158(3): 200-207.
15.	Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: consensus-based clinical case report guideline development. J Diet Suppl, 2013, 10(4): 381-390.
16.	Fu SF, Cheng CW, Zhang L, et al. Consensus-based recommendations for case report in Chinese medicine (CARC). Chin J Integr Med, 2016, 22(1): 73-79.

1. Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration. Ann Intern Med, 2017, 167(2): 112-121.
2. Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Traditional Chinese Version). Ann Intern Med, 2017, 167(2): W7-W20.
3. Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Simplified Chinese Version). Ann Intern Med, 2017, 167(2): W21-W34.
4. Macpherson H, Altman DG, Hammerschlag R. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med, 2010, 3(3): 35-46.
5. 尚志钧. 神农本草经校注. 北京: 学苑出版社, 2008.
6. Lewith GT, Aldridge D. Clinical research methodology for complementary therapies. London: Hodder and Stoughton, 1993.
7. 单平, 毛如宝, 徐济民, 等. 黄杨宁治疗冠心病-用双盲法观察 110 例临床疗效分析. 中医杂志, 1983, (5): 37-40.
8. Mcsp CS. Clinical Research Methodology for Complementary Therapies. Physiotherapy, 1993, 79(6):444.
9. Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg, 2011, 9(8): 672-677.
10. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg, 2010, 8(5): 336-341.
11. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev, 2015, 4(1): 1.
12. Stewart LA, Clarke M, Rovers M, et al. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD Statement. JAMA, 2015, 313(16): 1657-1665.
13. Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med, 2015, 162(11): 777-784.
14. Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med, 2013, 158(3): 200-207.
15. Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: consensus-based clinical case report guideline development. J Diet Suppl, 2013, 10(4): 381-390.
16. Fu SF, Cheng CW, Zhang L, et al. Consensus-based recommendations for case report in Chinese medicine (CARC). Chin J Integr Med, 2016, 22(1): 73-79.

Chinese Journal of Evidence-Based Medicine

Constructing the Chinese medicine clinical curative effects research report system

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content